These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 9051240

  • 41. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Boiron JM, Marit G, Fabéres C, Cony-Makhoul P, Foures C, Ferrer AM, Cristol G, Sarrat A, Girault D, Reiffers J.
    Bone Marrow Transplant; 1993 Jul; 12(1):49-55. PubMed ID: 8104070
    [Abstract] [Full Text] [Related]

  • 42. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
    Devereaux S, Linch DC, Gribben JG, McMillan A, Patterson K, Goldstone AH.
    Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
    [Abstract] [Full Text] [Related]

  • 43. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation.
    Roingeard F, Domenech J, Dayan A, Gihana E, Colombat P, Binet C.
    Bone Marrow Transplant; 1995 May; 15(5):741-7. PubMed ID: 7545488
    [Abstract] [Full Text] [Related]

  • 44. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM, Rosti G, Visani G, Gherlinzoni F, Miggiano MC, Fortuna A, Zinzani P, Tura S.
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [Abstract] [Full Text] [Related]

  • 45. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML, Fischer R, MacVittie TJ.
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [Abstract] [Full Text] [Related]

  • 46. Administration of GM-/G-CSF prior to bone marrow harvest increases collection of CD34+ cells.
    Slowman S, Danielson C, Graves V, Kotylo P, Broun R, McCarthy L.
    Prog Clin Biol Res; 1994 Feb; 389():363-9. PubMed ID: 7535443
    [Abstract] [Full Text] [Related]

  • 47. Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation.
    Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y.
    Exp Hematol; 1995 Jan; 23(1):8-13. PubMed ID: 7527786
    [Abstract] [Full Text] [Related]

  • 48. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Jan; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 49. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R, Imrie K, Spaner D, Potichnyj A, Robinson JB, Nanji S, Pennel N, Reis M, Pinkerton P, Dubé I, Hewitt K, Berinstein NL.
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [Abstract] [Full Text] [Related]

  • 50. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC, Klümpen HJ, Vyth-Dreese FA, Kersten MJ, Verra NC, Sein J, Batchelor D, Nooijen WJ, Schornagel JH.
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [Abstract] [Full Text] [Related]

  • 51. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R.
    Cancer; 2003 Dec 01; 98(11):2410-9. PubMed ID: 14635076
    [Abstract] [Full Text] [Related]

  • 52. [Mobilization of autologous peripheral blood stem cells by chemotherapy and recombinant granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Cui X, Shao Y, Ren B, Tong Z, Ren X, Li L, Zhang Z, Zhang N, Dai R, Hao X.
    Zhonghua Xue Ye Xue Za Zhi; 2000 May 01; 21(5):247-9. PubMed ID: 11876989
    [Abstract] [Full Text] [Related]

  • 53. Hematopoietic growth factor after autologous peripheral blood transplantation: comparison of G-CSF and GM-CSF.
    Jansen J, Thompson EM, Hanks S, Greenspan AR, Thompson JM, Dugan MJ, Akard LP.
    Bone Marrow Transplant; 1999 Jun 01; 23(12):1251-6. PubMed ID: 10414911
    [Abstract] [Full Text] [Related]

  • 54. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May 01; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 55. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb 01; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 56. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M.
    Haematologica; 2001 Jan 01; 86(1):44-51. PubMed ID: 11146570
    [Abstract] [Full Text] [Related]

  • 57. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL.
    Clin Invest Med; 1990 Apr 01; 13(2):77-81. PubMed ID: 2191816
    [Abstract] [Full Text] [Related]

  • 58. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
    Janik JE, Miller LL, Kopp WC, Taub DD, Dawson H, Stevens D, Kostboth P, Curti BD, Conlon KC, Dunn BK, Donegan SE, Ullrich R, Alvord WG, Gause BL, Longo DL.
    Clin Immunol; 1999 Dec 01; 93(3):209-21. PubMed ID: 10600331
    [Abstract] [Full Text] [Related]

  • 59. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
    Lefrère F, Hermine O, Audat F, Buzyn A, Cavazzana-Calvo M, Boccaccio C, Varet B.
    Hematol Cell Ther; 1998 Jun 01; 40(3):133-7. PubMed ID: 9698222
    [Abstract] [Full Text] [Related]

  • 60. Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
    Ippoliti C, Przepiorka D, Giralt S, Andersson BS, Wallerstein RO, Gutterman J, Deisseroth AB, Champlin RE.
    Bone Marrow Transplant; 1993 Jan 01; 11(1):55-9. PubMed ID: 8094309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.